ADFLU(Fludarabine)

Therapeutic class: Antimetabolite agent

Indication: B-cell Chronic Lymphocytic Leukemia (CLL) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent-containing regimen.